Valproate Toxicity: Risk-Screening Strategies
Open Access
- 1 January 1991
- journal article
- editorial
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 6 (1) , 3-6
- https://doi.org/10.1177/088307389100600101
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Fatal Liver Failure in 16 Children with Valproate TherapyEpilepsia, 1988
- A Suspected Case of Late-Onset Sodium-Valproate-lnduced Hepatic FailureNeuropediatrics, 1987
- A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: Possible clinical significanceLife Sciences, 1985
- Hyperammonemia and Valproate-Induced Alterations of the State of ConsciousnessEuropean Neurology, 1984
- Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytesBiochemical and Biophysical Research Communications, 1983
- Hyperammonemia with valproic acid therapyThe Journal of Pediatrics, 1981
- Recurrent Hypoglycemia Associated with Glutaric Aciduria Type II in an AdultNew England Journal of Medicine, 1979
- Treatment of accidental sodium valproate overdose with an opiate antagonistAnnals of Neurology, 1979
- Reye-like syndrome associated with valproic acid therapyThe Journal of Pediatrics, 1979
- Acute Hepatic Failure Associated with the Use of Sodium ValproateNew England Journal of Medicine, 1979